The Clinical Development Team at CureVac plays a pivotal role in advancing mRNA-based therapies through the design, execution, and oversight of clinical trials. Composed of experts in medical, regulatory, and operational domains, the team collaborates closely to ensure that innovative treatments are effectively translated from the laboratory to patient care while adhering to regulatory standards and optimizing trial efficiency. Their collective expertise drives the development of novel therapies targeting infectious diseases and beyond, ultimately contributing to CureVac’s mission of harnessing mRNA technology for transformative medical outcomes.
Dominique Denter-Erl...
Clinical Trial Supply Manager,...
Doris Mesia Vela
Medical Director Infectious Di...
Dr. Christoph Erbach...
Senior Manager Early Process D...
Julia Bosch
Senior Manager Regulatory Affa...
Maarten van Den Boer
Medical Director Infectious Di...
Margarida Mesquita
Medical Director - Infectious ...
Meryem Chennan
Senior Manager Regulatory Affa...
Stefanie Köhler
Senior Clinical Operations Ass...
Sybille Zitzmann
Associate Director Clinical Op...
Viola D.
Senior Clinical Biomarker Scie...
View all